Pregabalin Patent Expiration

Pregabalin is Used for treating neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia. It was first introduced by Upjohn Us 2 Llc in its drug Lyrica on Dec 30, 2004. Another drug containing Pregabalin is Lyrica Cr. 39 different companies have introduced drugs containing Pregabalin.


Pregabalin Patents

Given below is the list of patents protecting Pregabalin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lyrica Cr US10022447

(Pediatric)

Solid pharmaceutical compositions containing pregabalin May 02, 2027 Upjohn
Lyrica Cr US8945620

(Pediatric)

Solid pharmaceutical compositions containing pregabalin May 02, 2027 Upjohn
Lyrica Cr US9144559

(Pediatric)

Solid pharmaceutical compositions containing pregabalin May 02, 2027 Upjohn
Lyrica Cr US10022447 Solid pharmaceutical compositions containing pregabalin Nov 02, 2026 Upjohn
Lyrica Cr US8945620 Solid pharmaceutical compositions containing pregabalin Nov 02, 2026 Upjohn
Lyrica Cr US9144559 Solid pharmaceutical compositions containing pregabalin Nov 02, 2026 Upjohn
Lyrica US6001876

(Pediatric)

Isobutylgaba and its derivatives for the treatment of pain Jun 30, 2019

(Expired)

Upjohn
Lyrica US6197819

(Pediatric)

Gamma amino butyric acid analogs and optical isomers Jun 30, 2019

(Expired)

Upjohn
Lyrica USRE41920

(Pediatric)

Isobutylgaba and its derivatives for the treatment of pain Jun 30, 2019

(Expired)

Upjohn
Lyrica Cr US6197819

(Pediatric)

Gamma amino butyric acid analogs and optical isomers Jun 30, 2019

(Expired)

Upjohn
Lyrica Cr USRE41920

(Pediatric)

Isobutylgaba and its derivatives for the treatment of pain Jun 30, 2019

(Expired)

Upjohn
Lyrica US6001876 Isobutylgaba and its derivatives for the treatment of pain Dec 30, 2018

(Expired)

Upjohn
Lyrica US6197819 Gamma amino butyric acid analogs and optical isomers Dec 30, 2018

(Expired)

Upjohn
Lyrica USRE41920 Isobutylgaba and its derivatives for the treatment of pain Dec 30, 2018

(Expired)

Upjohn
Lyrica Cr US6197819 Gamma amino butyric acid analogs and optical isomers Dec 30, 2018

(Expired)

Upjohn
Lyrica Cr USRE41920 Isobutylgaba and its derivatives for the treatment of pain Dec 30, 2018

(Expired)

Upjohn
Lyrica US5563175 GABA and L-glutamic acid analogs for antiseizure treatment Oct 08, 2013

(Expired)

Upjohn



Pregabalin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pregabalin Generic API Manufacturers

Several generic applications have been filed for Pregabalin. The first generic version for Pregabalin was by Watson Laboratories Inc and was approved on Jul 3, 2012. And the latest generic version is by Jubilant Generics Ltd and was approved on May 20, 2025.

Given below is the list of companies who have filed for Pregabalin generic, along with the locations of their manufacturing plants worldwide.


Pregabalin News

Authorities in Sri Ganganagar have confiscated 50,000 capsules of Pregabalin and taken two individuals into custody.

15 Aug, 2025

See More